Scientists have discovered why the flu vaccine can perform poorly. They found that a specific type of immune cell, called T follicular helper cells, indirectly controls the anti-influenza response.
UBC researchers discover how to grow specialized immune cells for more accessible off-the-shelf cell therapies to treat cancer, autoimmune disorders and more. For the first time, researchers at the ...
A newly recognized set of T helper cells seems to guard against aging by eliminating harmful senescent cells. Their presence in supercentenarians suggests they may be a key to maintaining a healthier, ...
Researchers at the Medical University of Vienna have taken a closer look at a previously largely unknown component of the immune system: the protein molecule TRAT1 (T Cell Receptor Associated ...
Arabian Post on MSN
Breakthrough unlocks scalable helper T cell cancer therapies
Scientists have demonstrated a dependable method to generate large numbers of helper T cells from stem cells, removing a long-standing obstacle that has limited immune-based cancer treatments. The ...
(MEMPHIS, Tenn. – August 20, 2024) Scientists at St. Jude Children’s Research Hospital and Washington University School of Medicine have discovered why the flu vaccine can perform poorly. They found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results